Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Monash IVF Group.
RELATED STOCKHEAD STORIES
Experts
MoneyTalks: Here’s why 2022 is going to be a stock picker’s market
ScoPo’s Powerplays: ‘Market volatility could lead to a rally by Christmas’
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
Experts
ScoPo’s health powerplays: What to look for this earnings season
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
Experts
ScoPo’s powerplays: ‘It’s going to be a great run into 2021’
Experts
Scopo’s health powerplays: A healthy earnings season
Health & Biotech
Virtus pitches AI tech to get out of IVF price war
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Experts
Scopo’s powerplays: Hemp hippies and wellness wonderlands
News
Short & Caught: The ASX small caps investors are shorting right now
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
Director Trades
